Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Eugenia Verger"'
Publikováno v:
Medicina Paliativa. 25:61-65
Resumen Objetivos En este estudio se compararon los resultados de la radioterapia holocraneal (RTHC) con el tratamiento farmacologico exclusivo (TFE) respecto del control de sintomas y la mejoria en la funcion neurologica en pacientes con metastasis
Autor:
J. Puente, Jordi Bruna, Adela Bartolomé, Ana Laura Ortega, Eugenia Verger, Oscar Juan, Rafael López, Alejandro Navarro, Ernest Nadal, Santiago Ponce
Publikováno v:
Critical reviews in oncology/hematology. 138
The presence of an epidermal growth factor receptor (EGFR) mutation is associated with higher incidence of brain metastases in patients with non-small cell lung cancer (NSCLC); however, patients with synchronous brain metastases at diagnosis have gen
Autor:
Joan Berenguer, José Luis Blanch, Manuel Bernal-Sprekelsen, Africa Muxi, Juan J. Grau, Isabel Vilaseca, Eugenia Verger
Publikováno v:
Head & Neck. 38:1050-1057
Background Controversy exists regarding treatment of advanced laryngeal cancer. The purpose of this study was to evaluate the oncologic and functional outcomes of T3 to T4a supraglottic squamous carcinomas treated with transoral laser microsurgery (T
Autor:
Isabel Vilaseca, Eugenia Verger, Manuel Bernal-Sprekelsen, Africa Muxi, Juan J. Grau, José Luis Blanch, Anna Nogués-Sabaté, Joan Berenguer, Alfons Nadal, Francesc Xavier Avilés-Jurado
Publikováno v:
Headneck. 41(3)
BACKGROUND Indications of transoral laser microsurgery (TLM) are conditioned by the risk of local relapse. OBJECTIVE To evaluate prognostic factors of local relapse and local control with TLM (LC-TLM). METHODS Local relapse and LC-TLM were evaluated
Autor:
Miguel Gil-Gil, R. Luque, Carlos Mesia, Ana Herrero, Gaspar Reynes, Iris Teruel, Juan Manuel Sepúlveda, Andrés F. Cardona, J. Marruecos, M. Hardy-Werbin, Maria Martinez-Garcia, Alfonso Berrocal, Pedro Pérez-Segura, Carmen Balana, Anna Estival, R. Fuentes, C Panciroli, Eugenia Verger, S. del Barco, Oscar Gallego, R. de las Peñas, J.M. Velarde, S. Villà, Estela Pineda
Publikováno v:
CLINICAL & TRANSLATIONAL ONCOLOGY
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
Clinical & Translational Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
Clinical & Translational Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
PurposeWe retrospectively examined the potential effect on overall survival (OS) of delaying radiotherapy to administer neoadjuvant therapy in unresected glioblastoma patients.Patients and methodsWe compared OS in 119 patients receiving neoadjuvant t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15211af401d36ccb79f3f7bbc83c4686
https://fundanet.fihgu.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1324
https://fundanet.fihgu.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1324
Autor:
M. Benavides, Estela Pineda, A. Sánchez, Pedro Pérez-Segura, Pilar Teixidor, Miriam Crespo Alonso, Ana Ramos, Carmen Balana, Eugenia Verger, Aurelio Hernández-Laín
The SEOM/GEINO clinical guidelines provide recommendations for radiological, and molecular diagnosis, treatment and follow-up of adult patients with anaplastic gliomas (AG). We followed the 2016 WHO classification which specifies the major diagnostic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05387ee47513765e2c3f8ddfb0f5457b
https://hdl.handle.net/10668/12534
https://hdl.handle.net/10668/12534
Autor:
C. Balana, Sonia Del Barco, Juan Sepulveda, Eugenia Verger, Jose Maria Velarde, Juan José García Mosquera, Anna Estival, Ana Herrero, Maria Martinez Garcia, M. Gil, Raquel Luque, Carlos Mesia, Iris Teruel, Salvador Villà, Ramon De Las Penas, Oscar Gallego, Estela Pineda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::754077f49640642ac373c1ca377d8bc1
https://europepmc.org/articles/PMC5692347/
https://europepmc.org/articles/PMC5692347/
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 273:2193-2199
Although cetuximab plus radiotherapy is a standard treatment for patients with inoperable head and neck squamous cell carcinoma (HNSCC), its efficacy varies greatly among individuals. To identify predictive markers of efficacy, we examined the effect
Autor:
Sofia Gonzalez, Carmen Balana, Eugenia Verger, Miguel J. Gil, Pedro Perez, Teresa Ribalta, Jaume Capellades, Oscar Gallego, Gaspar Reynes
Publikováno v:
Targeted Oncology. 9:321-329
Sunitinib is a tyrosine kinase inhibitor with direct anti-tumor and anti-angiogenesis activity targeting VEGFR 1-2, PDGFR α-β, c-kit, bFGF, (CSF-1), FLT3 and RET. The present trial examined the activity of sunitinib in 12 patients with newly diagno
Autor:
Jordi Bruna, M. Gil, Palmira Foro, J.M. Sepulveda Sanchez, A. Hernandez Lain, Jaume Capellades, F. Alameda, M.C. Martin Soberon, Guillermo Velasco, M. Martinez Garcia, Eugenia Verger, C. Mesia Barroso, Estela Pineda, B. Sarmiento, A. Taus Garcia
Publikováno v:
Annals of Oncology. 30:v147
Background MET signaling has a role in gliomagenesis and glioma stem cell maintenance and midkine (ALK ligand) promotes resistance of glioma cells to anticancer therapies. Crizotinib is an ALK and c-MET inhibitor with a preclinical rationale to be te